CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 256 filers reported holding CYTOKINETICS INC in Q3 2023. The put-call ratio across all filers is 2.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $204,256 | +10.8% | 6,935 | +27.0% | 0.00% | – |
| Q2 2023 | $184,264 | +1.2% | 5,461 | +5.3% | 0.00% | – |
| Q1 2023 | $182,110 | -24.6% | 5,187 | -1.9% | 0.00% | – |
| Q4 2022 | $241,558 | -48.3% | 5,286 | -45.1% | 0.00% | -100.0% |
| Q3 2022 | $467,000 | -52.9% | 9,633 | -61.8% | 0.00% | -50.0% |
| Q2 2022 | $992,000 | +544.2% | 25,186 | +324.7% | 0.00% | – |
| Q1 2022 | $154,000 | -34.5% | 5,930 | +14.9% | 0.00% | – |
| Q4 2021 | $235,000 | +55.6% | 5,163 | +23.4% | 0.00% | – |
| Q3 2021 | $151,000 | +81.9% | 4,184 | +2.1% | 0.00% | – |
| Q2 2021 | $83,000 | -9.8% | 4,097 | +5.0% | 0.00% | – |
| Q1 2021 | $92,000 | +67.3% | 3,901 | +43.2% | 0.00% | – |
| Q4 2020 | $55,000 | +66.7% | 2,725 | +97.0% | 0.00% | – |
| Q3 2020 | $33,000 | 0.0% | 1,383 | 0.0% | 0.00% | – |
| Q2 2020 | $33,000 | +83.3% | 1,383 | -7.1% | 0.00% | – |
| Q1 2020 | $18,000 | – | 1,489 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 4,989,218 | $47,348,000 | 10.09% |
| EcoR1 Capital, LLC | 2,139,697 | $20,306,000 | 8.01% |
| Healthcare Value Capital, LLC | 100,000 | $949,000 | 1.15% |
| DAFNA Capital Management LLC | 150,000 | $1,424,000 | 1.13% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 151,106 | $1,434,000 | 1.07% |
| Avoro Capital Advisors LLC | 503,900 | $4,782,000 | 1.06% |
| ACUTA CAPITAL PARTNERS, LLC | 140,969 | $1,338,000 | 0.64% |
| Iguana Healthcare Management, LLC | 150,000 | $1,424,000 | 0.58% |
| WASATCH ADVISORS LP | 1,746,096 | $16,570,000 | 0.25% |
| Virtus ETF Advisers LLC | 29,379 | $279,000 | 0.21% |